EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

The Angiogenic Markers PlGF and sFlt-1 in Cytomegalovirus Infection During Pregnancy: Insights from a Clinical Case

Valentina Giardini iD, Ramona Chiozzi, Federica Fernicola iD, Marco Casati iD, Anna Locatelli iD, Sara Ornaghi iD

Viruses · 2025

DOI: 10.3390/v17020267 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Viruses, 2025. Verfasst von Valentina Giardini und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Obstetrics, Foundation IRCCS San Gerardo dei Tintori, 20900 Monza, Italy. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Vascular Endothelial Growth Factor Receptor-1, Placenta Growth Factor, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytomegalovirus (CMV) infection during pregnancy is the leading cause of congenital infection subsequent to viral transplacental transmission. CMV placental infection can contribute to the development of adverse outcomes likely through placental dysfunction. This case report shows the potential utility of angiogenic markers, such as placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1), in assessing CMV-related placental involvement and monitoring the effect of antiviral therapy on placental function, and highlights the possibility of integrating these markers into the clinical management of CMV infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytomegalovirus InfectionsVascular Endothelial Growth Factor Receptor-1Placenta Growth FactorPregnancy Complications, InfectiousHumansPregnancyFemaleBiomarkersAdultPlacentaCytomegalovirusInfectious Disease Transmission, VerticalAntiviral Agents

Stichwörter der Autor:innen

PlGFangiogenic markerscytomegalovirusinfectionplacental dysfunctionsFlt-1sFlt-1/PlGF

Substanzen

Vascular Endothelial Growth Factor Receptor-1Placenta Growth FactorBiomarkersFLT1 protein, humanPGF protein, humanAntiviral Agents

Autor:innen und Institutionen

  • Unit of Obstetrics, Foundation IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
  • Specialization School in Obstetrics and Gynecology, University of Milano-Bicocca, 20900 Monza, Italy.
  • Laboratory Medicine, Foundation IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
  • School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.

ORCID-Profile: Valentina Giardini, Federica Fernicola, Marco Casati, Anna Locatelli, Sara Ornaghi

Zitieren

APA

Giardini, V., Chiozzi, R., Fernicola, F., Casati, M., Locatelli, A., & Ornaghi, S. (2025). The Angiogenic Markers PlGF and sFlt-1 in Cytomegalovirus Infection During Pregnancy: Insights from a Clinical Case. Viruses. https://doi.org/10.3390/v17020267

Vancouver

Giardini V, Chiozzi R, Fernicola F, Casati M, Locatelli A, Ornaghi S. The Angiogenic Markers PlGF and sFlt-1 in Cytomegalovirus Infection During Pregnancy: Insights from a Clinical Case. Viruses. 2025. doi:10.3390/v17020267

BibTeX
@article{Giardini2025,
  author = {Giardini, Valentina and Chiozzi, Ramona and Fernicola, Federica and Casati, Marco and Locatelli, Anna and Ornaghi, Sara},
  title = {The Angiogenic Markers PlGF and sFlt-1 in Cytomegalovirus Infection During Pregnancy: Insights from a Clinical Case},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17020267}
}
Kostenlos starten →